Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
Cardiac fibrosis is associated with most forms of cardiovascular disease. No reliable therapies targeting cardiac fibrosis are available, thus identifying novel drugs that can resolve or prevent fibrosis is needed. Tilorone, an antiviral agent, can prevent fibrosis in a mouse model of lung disease....
Main Authors: | Duncan Horlock, David M. Kaye, Catherine E. Winbanks, Xiao-Ming Gao, Helen Kiriazis, Daniel G. Donner, Paul Gregorevic, Julie R. McMullen, Bianca C. Bernardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/263 |
Similar Items
-
Study of intermolecular interactions of antiviral agent tilorone with RNA and nucleosides
by: V. A. Pashynska, et al.
Published: (2018-05-01) -
An Effective Synthesis Method for Tilorone Dihydrochloride with Obvious IFN-α Inducing Activity
by: Junren Zhang, et al.
Published: (2015-12-01) -
Antiviral Activity of Metal-Containing Polymers—Organotin and Cisplatin-Like Polymers
by: Girish Barot, et al.
Published: (2011-05-01) -
Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure
by: A V Budnevsky, et al.
Published: (2019-03-01) -
THERAPY OPTIMIZATION OF INFLUENZA AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS IN PEDIATRIC PRACTICE
by: G. P. Martynova, et al.
Published: (2012-04-01)